Perimenopause Misdiagnosis: Why Nearly 40% of Women Get the Wrong Diagnosis First

You went to your doctor. You described the brain fog, the mood swings, the sleep disruption, the anxiety that arrived out of nowhere in your late 30s or early 40s. You walked out with a prescription for an antidepressant, a referral to a therapist, or a suggestion to "reduce stress."

What you didn't walk out with was a correct diagnosis.

If this sounds familiar, you are not an outlier. You are part of a pattern so consistent it has now been documented across multiple national surveys — and the numbers warrant a closer look.

Nearly 40% of Women Seeking Perimenopause Care Are Misdiagnosed

A 2025 national survey of more than 1,000 U.S. women ages 30 to 60, commissioned by Biote, found that nearly 40% of women felt they had been misdiagnosed when seeking care for perimenopause symptoms.¹

The most common misdiagnoses? Anxiety. Depression. Mood disorders. Panic attacks. Over half of the women surveyed had been treated for one of these conditions since entering perimenopause. Among those prescribed psychiatric medication, 39% believed they had not received the right diagnosis at all.¹

This is not a story about bad doctors. It is a story about a healthcare system that was built without adequate knowledge of what happens to women's bodies during perimenopause — and has never fully corrected that gap.

The Training Gap Behind the Misdiagnosis Rate

The misdiagnosis rate does not exist in isolation. It is the downstream consequence of a structural problem in medical education.

Fewer than 20% of U.S. primary care physicians receive formal menopause training as part of their medical education.² The same shortage exists at the specialist level: only 6.8% of OB-GYN and primary care residents reported feeling adequately prepared to manage women experiencing perimenopause and menopause, according to a 2024 survey by The Menopause Society.³ Just 31% of U.S. OB-GYN residency programs include any dedicated menopause curriculum.⁴

Among residents who do receive menopause education, approximately 80% describe themselves as "barely comfortable" discussing or treating menopause.²

The result is a generation of physicians who are clinically trained to treat the symptoms they recognize — anxiety, depression, sleep disorders, cognitive complaints — without the hormonal context that would explain why those symptoms are appearing together, in this patient, at this age, at this point in her cycle.

Most Women Weren't Informed — And Aren't Getting the Conversation They Need

The problem begins before women ever see a physician. Only 15% of women in the Biote survey reported feeling adequately informed about perimenopause when their symptoms first began — meaning 85% were navigating an unfamiliar hormonal transition without enough information to recognize what was happening.¹

When women did seek answers, the data on where they found them is revealing: 42% turned to Google. 42% asked family members. Only 26% received information about perimenopause from their primary care provider or OB-GYN.¹

Even when women did initiate a conversation with a provider, only 42% reported that their doctor had proactively raised the subject of perimenopause during a routine appointment.¹ And among women who did have that conversation, nearly 1 in 5 felt their concerns were not taken seriously or fully addressed.¹

The Delay Between Symptoms and Diagnosis

For many women, the gap between first symptoms and a correct diagnosis is not weeks. It is years.

Approximately 20% of women wait more than 12 months for a formal diagnosis of their menopause transition.⁵ A separate analysis found that 1 in 3 women aged 45 to 54 had been diagnosed with a different health condition entirely before their symptoms were correctly attributed to menopause.⁶ At the furthest end of the spectrum, roughly 5% of women saw 11 or more doctors before receiving appropriate support.⁷

These delays have real consequences. Perimenopause is not only a reproductive transition — it is a period during which estrogen fluctuations affect the brain, the cardiovascular system, bone density, immune function, and metabolic health. Women who spend years being treated for anxiety they may not have had are not receiving the information, resources, or interventions that could support their health during this window.

When Complexity Compounds the Problem

For women managing chronic conditions alongside perimenopause, the misdiagnosis landscape becomes more layered still.

Estrogen directly regulates dopamine function. As estrogen fluctuates during perimenopause, women with ADHD commonly report a significant amplification of their symptoms — impaired focus, executive dysfunction, emotional dysregulation — that can be mistaken for new-onset psychiatric illness rather than the intersection of two existing realities.

Similarly, Hashimoto's thyroiditis, PCOS, POTS, and autoimmune conditions share overlapping symptom profiles with perimenopause. Fatigue, brain fog, mood instability, weight changes — each of these can be attributed to the wrong underlying cause when perimenopause is not part of the clinical picture.

What Changes the Outcome

Research consistently identifies a small number of factors that improve diagnostic outcomes for women in perimenopause:

• Symptom documentation. Women who arrive at appointments with a detailed log of their symptoms — timing, severity, relationship to their cycle — are harder to dismiss. Pattern data creates a clinical record that is more difficult to attribute to stress or anxiety alone.
• Naming it directly. Only 42% of clinicians initiate the perimenopause conversation. Women who name it explicitly — "I think I may be in perimenopause and I want to discuss it" — change the terms of the appointment.¹
• Access to the underlying research. The evidence base for perimenopause and its relationship to hormonal, neurological, and immune function exists. The gap is not in the science — it is in how accessible that science is to the women who need it, and to the providers who treat them.

A Note on What FemWiseIQ Is and Is Not

FemWiseIQ is not a diagnostic tool. We do not interpret lab results as medical advice, and we do not replace clinical care. What we do is synthesize peer-reviewed research from PubMed, Europe PMC, CORE, and the NIH — and surface what is relevant to your specific conditions, symptoms, and life stage.

If the statistics in this article describe your experience, that experience is documented, studied, and real. And there is a significant body of research that can help you understand it.